The Italian startup AorticLab closed a round of €1.3 million with the equity crowdfunding campaign on the Doorway, the business angels of Italian Angels for Growth (IAG) and Investors’ Club.
AorticLab is currently developing a low invasiveness system for the functional restoration of the native aortic valve affected by calcium dystrophy. The system, based on transcatheter technology, is inserted through the femoral artery and consists of two devices that operate independently. An innovative ultrasound scaler that fragments the calcific formations in the valve flaps promoting the functional recovery of the aortic valve. The second device is an anti-embolic filter with the function of capturing the blood or calcific emboli generated during the procedure. The filter can be advantageously used individually during the implantation of transcatheter valve prostheses (TAVI).